These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18483394)

  • 1. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma.
    Chen RW; Bemis LT; Amato CM; Myint H; Tran H; Birks DK; Eckhardt SG; Robinson WA
    Blood; 2008 Aug; 112(3):822-9. PubMed ID: 18483394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.
    Wiestner A; Tehrani M; Chiorazzi M; Wright G; Gibellini F; Nakayama K; Liu H; Rosenwald A; Muller-Hermelink HK; Ott G; Chan WC; Greiner TC; Weisenburger DD; Vose J; Armitage JO; Gascoyne RD; Connors JM; Campo E; Montserrat E; Bosch F; Smeland EB; Kvaloy S; Holte H; Delabie J; Fisher RI; Grogan TM; Miller TP; Wilson WH; Jaffe ES; Staudt LM
    Blood; 2007 Jun; 109(11):4599-606. PubMed ID: 17299095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation.
    Menke JR; Vasmatzis G; Murphy S; Yang L; Menke DM; Tun HW; King RL; Smoley SA; Ketterling RP; Sukov WR
    Hum Pathol; 2017 Jun; 64():207-212. PubMed ID: 28132860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
    Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
    BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma.
    Zhao JJ; Lin J; Lwin T; Yang H; Guo J; Kong W; Dessureault S; Moscinski LC; Rezania D; Dalton WS; Sotomayor E; Tao J; Cheng JQ
    Blood; 2010 Apr; 115(13):2630-9. PubMed ID: 20086245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma.
    Mohanty A; Sandoval N; Das M; Pillai R; Chen L; Chen RW; Amin HM; Wang M; Marcucci G; Weisenburger DD; Rosen ST; Pham LV; Ngo VN
    Oncotarget; 2016 Nov; 7(45):73558-73572. PubMed ID: 27713153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific transcript variants of cyclin D1 in mantle cell lymphoma and multiple myeloma with chromosome 11q13 abnormalities.
    Chinen Y; Tsukamoto T; Maegawa-Matsui S; Matsumura-Kimoto Y; Takimoto-Shimomura T; Tanba K; Mizuno Y; Fujibayashi Y; Kuwahara-Ota S; Shimura Y; Kobayashi T; Horiike S; Taniwaki M; Kuroda J
    Exp Hematol; 2020 Apr; 84():45-53.e1. PubMed ID: 32145384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphoma.
    Masamha CP; Albrecht TR; Wagner EJ
    J Hematol Oncol; 2016 Mar; 9():30. PubMed ID: 27025456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias.
    Rimokh R; Berger F; Bastard C; Klein B; French M; Archimbaud E; Rouault JP; Santa Lucia B; Duret L; Vuillaume M
    Blood; 1994 Jun; 83(12):3689-96. PubMed ID: 8204893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines.
    Tiemann K; Alluin JV; Honegger A; Chomchan P; Gaur S; Yun Y; Forman SJ; Rossi JJ; Chen RW
    Leuk Lymphoma; 2011 Nov; 52(11):2148-54. PubMed ID: 21745168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma.
    Williams ME; Nichols GE; Swerdlow SH; Stoler MH
    Ann Oncol; 1995 Mar; 6(3):297-9. PubMed ID: 7612496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miR-15b as a transformation-related factor in mantle cell lymphoma.
    Arakawa F; Kimura Y; Yoshida N; Miyoshi H; Doi A; Yasuda K; Nakajima K; Kiyasu J; Niino D; Sugita Y; Tashiro K; Kuhara S; Seto M; Ohshima K
    Int J Oncol; 2016 Feb; 48(2):485-92. PubMed ID: 26676972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest.
    Sun F; Fu H; Liu Q; Tie Y; Zhu J; Xing R; Sun Z; Zheng X
    FEBS Lett; 2008 Apr; 582(10):1564-8. PubMed ID: 18406353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11.
    Zhou K; Feng X; Wang Y; Liu Y; Tian L; Zuo W; Yi S; Wei X; Song Y; Qiu L
    Exp Hematol; 2018 Feb; 58():27-34.e1. PubMed ID: 29158064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma.
    Liu H; Huang J; Wang J; Jiang S; Bailey AS; Goldman DC; Welcker M; Bedell V; Slovak ML; Clurman B; Thayer M; Fleming WH; Epner E
    J Exp Med; 2008 Aug; 205(8):1843-58. PubMed ID: 18625744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.
    Wlodarska I; Dierickx D; Vanhentenrijk V; Van Roosbroeck K; Pospísilová H; Minnei F; Verhoef G; Thomas J; Vandenberghe P; De Wolf-Peeters C
    Blood; 2008 Jun; 111(12):5683-90. PubMed ID: 18391076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.
    Hui P; Howe JG; Crouch J; Nimmakayalu M; Qumsiyeh MB; Tallini G; Flynn SD; Smith BR
    Leuk Lymphoma; 2003 Aug; 44(8):1385-94. PubMed ID: 12952233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
    Ek S; Dictor M; Jerkeman M; Jirström K; Borrebaeck CA
    Blood; 2008 Jan; 111(2):800-5. PubMed ID: 17934069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.